IP Verse

Laboratoire Francais Du Fractionnement Des Biotechnologies competitive analysis

Latest oppositions filed by Laboratoire Francais Du Fractionnement Des Biotechnologies

Explore patent oppositions filed by Laboratoire Francais Du Fractionnement Des Biotechnologies against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
EP2073842
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of AntibodiesGLYCOTOPESep 29, 2015
EP2302076
Methods And Reagents For Treatment And Diagnosis Of Age-Related Macular DegenerationUNIVERSITY OF IOWA RESEARCH FOUNDATIONAug 12, 2015
EP1711513
Nanofiltration Of Factor Vii Solutions To Remove VirusNOVO NORDISK HEALTH CAREApr 2, 2015

Latest PTAB cases involving Laboratoire Francais Du Fractionnement Des Biotechnologies

Discover the latest PTAB cases involving Laboratoire Francais Du Fractionnement Des Biotechnologies, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 15, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Laboratoire Francais Du Fractionnement Des Biotechnologies

IPR2017-00028Oct 7, 2016LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIESCHRISTENSENFinal Written Decision
IPR2017-00028Oct 7, 2016LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIESNOVO NORDISK HEALTHCAREFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Laboratoire Francais Du Fractionnement Des Biotechnologies with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES3 - 1 -
CHRISTENSEN - - - 2
GLYCOTOPE - 7 - -
NOVO NORDISK HEALTHCARE - - - 1